AN2 Therapeutics, Inc. (NasdaqGS: ANTX)
Health Care · Pharmaceuticals · US
$4.68
-3.51% today · +270.2% 1Y
AN2 Therapeutics, Inc. (NasdaqGS: ANTX) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $183.02M and employs 21 people.
Over the last twelve months the share price has gained 270.2%, trading between 1.00 and 7.19.
Tweenvest scores AN2 Therapeutics, Inc. across four factors: quality 35/100, value 64/100. Its strongest factor is value.
ANTX price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $183.02M
- Revenue (TTM)
- —
- P/E
- —
- EPS
- -1.04
- Dividend yield
- —
- Beta (5Y)
- -0.98
- 52-week high
- $7.19
- 52-week low
- $1.00
- Avg volume (3M)
- —
- Shares outstanding
- 37.74M
- Employees
- 21
- Next earnings
- —
About AN2 Therapeutics, Inc.
AN2 Therapeutics, Inc. is a biopharmaceutical company currently in its clinical development phase, specializing in the creation of treatments for uncommon, long-term, and severe infectious conditions. A key focus of their pipeline is epetraborole, an investigational oral medication designed for once-daily administration to individuals battling chronic non-tuberculous mycobacterial lung disease. This enterprise was established in 2017 and operates from its headquarters situated in Menlo Park, California.
- ISIN
- US0373261058
- Founded
- 2017
- Listed since
- Mar 25, 2022
- Exchange
- Nasdaq Global Select
- Currency
- USD
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Orient Pharma Co., Ltd.TPEX: 4166 | $186.16M | NT$24.40 | +1.67% |
| Korea United Pharm Inc.KOSE: A033270 | $186.00M | ₩17,530.00 | -0.57% |
| Yoda Pharmaceuticals Inc.TPEX: 7829 | $184.39M | NT$59.10 | -2.15% |
| Dawnrays Pharmaceutical (Holdings) LimitedSEHK: 2348 | $184.26M | HK$0.96 | -0.52% |
| MINAPHARM PharmaceuticalsCASE: MIPH | $182.84M | EGP812.49 | +0.32% |
| Formosa Laboratories, Inc.TWSE: 4746 | $181.58M | NT$48.10 | +0.10% |
| Anlon Healthcare LimitedNSEI: AHCL | $181.40M | Rs32.86 | +4.28% |
| Fidson Healthcare PlcNGSE: FIDSON | $178.88M | ₦82.00 | -3.53% |
Figures last refreshed Oct 4, 2026.